Yufei Bo
Impact in
-
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
-
- IL-33, ST2, and ILC Pathways 2
- T-cell and B-cell Immunology 2
- Atherosclerosis and Cardiovascular Diseases 1
-
- Single-cell and spatial transcriptomics 2
- Co-authors
- Linnan Zhu (4 shared papers)Zemin Zhang (2 shared papers)Dongfang Wang (2 shared papers)Wenhong Hou (2 shared papers)Jianan Li (2 shared papers)Shishang Qin (2 shared papers)Lu Qi (1 shared paper)Zhigang Tian (1 shared paper)
- Journals
- Cell (2 papers)Cancer Cell (2 papers)Cellular and Molecular Immunology (1 paper)Cellular & Molecular Biology Letters (1 paper)Cell Reports (1 paper)
- Partner nations
- China
In The Last Decade
Yufei Bo
6 papers receiving 395 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Immunology 193
- Oncology 195
- Cancer Research 76
- Molecular Biology 141
- Pulmonary and Respiratory Medicine 61
Countries citing papers authored by Yufei Bo
This map shows the geographic impact of Yufei Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Bo more than expected).
Fields of papers citing papers by Yufei Bo
This network shows the impact of papers produced by Yufei Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Bo. The network helps show where Yufei Bo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yufei Bo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A pan-cancer single-cell panorama of human natural killer cells Hit paper breakdown → | 2023 | 187 |
| 2 | Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation Hit paper breakdown → | 2024 | 83 |
| 3 | Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes Hit paper breakdown → | 2024 | 63 |
| 4 | Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer Hit paper breakdown → | 2024 | 62 |
| 5 | 2024 | 1 | |
| 6 | 2025 | 1 | |
| 7 | 2025 | 0 |
About Yufei Bo
Yufei Bo is a scholar working on Immunology, Molecular Biology, Oncology, Nephrology and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 397 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Single-cell and spatial transcriptomics (2 papers), IL-33, ST2, and ILC Pathways (2 papers), T-cell and B-cell Immunology (2 papers), Renal Diseases and Glomerulopathies (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Immunology (193 citations), Oncology (195 citations), Cancer Research (76 citations), Molecular Biology (141 citations) and Pulmonary and Respiratory Medicine (61 citations). Yufei Bo has collaborated with scholars based in China. Frequent co-authors include Linnan Zhu, Zemin Zhang, Dongfang Wang, Wenhong Hou, Jianan Li, Shishang Qin, Lu Qi, Zhigang Tian, Fei Tang and Dongfang Liu. Their work appears in journals such as Cell, Cancer Cell, Cellular and Molecular Immunology, Cellular & Molecular Biology Letters and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.